Search

Your search keyword '"Fabbrocini A"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Fabbrocini A" Remove constraint Author: "Fabbrocini A" Publisher elsevier bv Remove constraint Publisher: elsevier bv
127 results on '"Fabbrocini A"'

Search Results

4. Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: a multicenter retrospective study

7. Trichoscopy findings of frontal fibrosing alopecia on the eyebrows: A study of 151 cases

9. Clinical characterization and treatment outcomes of follicular cutaneous immune–related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study

11. Guselkumab and risankizumab for psoriasis: a 44-week indirect real-life comparison

19. Sonidegib efficacy and tolerability in advanced basal cell carcinoma: A single-center real-life experience

20. Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions

21. A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents

22. Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment

23. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?

24. Prurigo nodularis and pembrolizumab: A therapeutic challenge

29. Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series

33. Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS

35. Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy

38. Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS

39. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group

40. The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients

42. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?

43. Ground Ulva solution (GUS): A promising metamorphosis cue for Paracentrotus lividus larviculture

48. PSS3 Cost-Effectiveness Analysis of Biologic Treatments for Plaque Psoriasis in Italy: Results of the Canova Study

50. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?

Catalog

Books, media, physical & digital resources